|
Tuesday, 29 January 2008 |
|
The following statement was made by the Coalition for the Advancement
of Medical Research (CAMR) regarding President Bush's comments on an
important health care issue during the State of the Union Address on
January 28. The Parkinson’s Action Network (PAN) fully
supports this statement.
|
|
|
Friday, 18 January 2008 |
|
The
following statement was made by the Coalition for the Advancement of Medical
Research (CAMR), concerning recent news reports (including the January 18
edition of the Washington Post) that
chronicle a recent breakthrough in the cloning of human embryos. The Parkinson’s Action Network (PAN) fully
supports this statement.
|
|
|
Thursday, 10 January 2008 |
|
On January 9, Monnie Lindsay, PAN’s Nebraska State Coordinator and member of PAN’s Board of Directors was featured during a television report on a breakthrough that researchers at the University of Nebraska Medical Center believe could lead to a vaccine that would treat Parkinson’s disease. Lindsay was interviewed by Fox affiliate KPTM in Omaha, Neb. To view the written story and the television report, click here. |
|
|
Wednesday, 12 December 2007 |
On Wednesday, December 12, Amy Comstock Rick, CEO of the Parkinson’s
Action Network (PAN) was elected as the new president of The Coalition
for the Advancement of Medical Research (CAMR), effective January 1, 2008.
|
|
|
Friday, 07 December 2007 |
|
The following article was published in the December 7 edition of the
Washington Post. It describes an article published in the
December 6 online edition of the journal Science, detailing stem cell
research similar to the breakthrough announced on November 20, in which
skin cells were induced to a pluripotent state.
|
|
|
Monday, 26 November 2007 |
|
The following article is an editorial that appeared in the Seattle Times on Monday, November 26.
|
|
|
Wednesday, 21 November 2007 |
|
On Tuesday evening, PAN CEO Amy Comstock Rick appeared on “Global National,” a newscast that airs throughout Canada on the Global TV Network. Rick commented on the recent stem cell research breakthrough that was reported on Tuesday. To view the piece, click here. For PAN’s official statement on the breakthrough, please see the article below. |
|
|
Tuesday, 20 November 2007 |
|
The Parkinson’s Action Network (PAN) is pleased by the news of a
breakthrough in stem cell research, in which scientific researchers
have created embryonic-like cells from ordinary human skin cells,
without using embryos through the process of cloning.
|
|
|
Thursday, 15 November 2007 |
|
On Friday, November 9, Monnie Lindsay, PAN’s Nebraska State Coordinator
and member of PAN’s Board of Directors testified in favor of embryonic
stem cell research (ESCR) at an Interim Study Hearing, held by the
Judiciary Committee of the Nebraska State Legislature in Lincoln.
|
|
|
Wednesday, 07 November 2007 |
|
The Parkinson’s Action Network
participated in a Food and Drug Administration (FDA) hosted conference on
November 6-7 entitled “Assessing Drug Benefits and Risks in Regulatory
Decisions: Framing the Need, Evaluating the Tools, and Deciding Next Steps,” in
Silver Spring, Md. The conference attendees were
primarily FDA regulators and representatives from the pharmaceutical and
biotech industries. |
|
|
Friday, 02 November 2007 |
Printed Friday, November 2, 2007 in the Newark Star-Ledger
by Wise Young, Richard H. Shindell chairman in neuroscience at the W.M.
Keck Center for Collaborative Neuroscience at Rutgers University
|
|
|
Thursday, 18 October 2007 |
PAN's Connecticut State Coordinator, Bob Mandelkern was featured in an article that appeared on the London South East Web site, chronicling his state's request to increase stem cell research funding.
|
|
|
Monday, 24 September 2007 |
|
On September 12, the
Parkinson’s Action Network, along with the Alliance for Aging Research and the
Alzheimer’s Association hosted a congressional briefing on the growing burden
of neurological diseases and the promise of innovation. Amy Comstock Rick, PAN’s CEO, and Paula Wittekind,
PAN’s Florida State Coordinator, discussed the needs of the Parkinson’s disease
community with Congressional staff and other patient advocacy organizations.
|
|
|
Thursday, 19 July 2007 |
The U.S. Department of Defense has announced partial allocation of its $900 million to use for Traumatic Brain Injury (TBI) and Post Traumatic Stress Disorder (PTSD). The funding came on May 25, when the President signed into law the Emergency Supplemental Appropriations Bill that provides, among other things, the funding for treatment and research of PTSD and TBI.
|
|
|
Wednesday, 18 July 2007 |
|
The Coalition for a Stronger FDA, of which the Parkinson’s Action Network (PAN)
is a member organization, has voiced its appreciation to members of the Senate
Agriculture Appropriations Subcommittee, led by Chairman Herbert Kohl and
Ranking Member Robert Bennett, for their efforts to increase the Food and Drug Administration’s budget. |
|
Powered by Phase2 Technology